At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PrEP Point-of-Care Brief-Intervention for Adherence Among Young Men Who Have Sex With Men
In Brief
A clinical study evaluating Motivational Interviewing Counselling and Point-of-care Urine Tenofovir Measurement for Risk Reduction. Completed, enrolled 63 participants across 1 site.
Detailed Summary
Despite advances in HIV prevention, the HIV incidence among young men who have sex with men (YMSM) is increasing, threatening to derail achievement of the United States End the HIV Epidemic goals. Although, pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention method, adherence was sufficiently low to comprise efficacy among a high proportion of YMSM in multiple clinical trials and demonstration projects. In this study, the investigators will leverage a novel urine point-of-care drug-level test for PrEP adherence, to both enhance and target motivational-interviewing-based adherence counseling among YMSM, with the goal of preventing HIV infections among this critically at-risk group.
Study Details
Timeline
Interventions
Motivational interviewing-based counseling will be provided to the participant based on the results of the urine test
Urine will be collected and the presence or absence of tenofovir will be measured with the point-of-care urine tenofovir test.